Citations

Showing 10 of 108094 citations.

Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC)
Jenkins, Mark A. , Win, Aung Ko , Templeton, Allyson , Angelakos, Maggie S, Buchanan, Daniel D. , Cotterchio, Michelle , Figueiredo, Jane C. , Thibodeau, Stephen N. , Gallinger, Steven, Lindor, Noralane M. , Haile, Robert W. , Investigators, Colon Cancer Family Registry Cohort, Ahnen, Dennis J. , Anton, Kristen , Arnold, Julie, Aronson, Melyssa , Aujard, Kelly, Bapat, Bharati , Barker, Melissa, Bickerstaffe, Adrian , Burnett, Terrilea, Daftary, Darshana, DeRycke, Melissa S. , Dicks, Elizabeth , Diep, Anh, Duggan, Dave , Fisher, Douglass, Fox, Samantha , French, Amy J. , Glanz, Karen, Goldblatt, Jack, Goldberg, Richard M. , Goode, Ellen L. , Greenberg, Cary, Green, Jane , Green, Roger, Grove, John H. , Gryfe, Robert, Harmon, Patricia, Holowaty, Eric J., Holter, Spring, Kim, Hyeja, Kirk, Judy, Lance, Peter , Laurino, Mercy , Leggett, Barbara , Levine, A. Joan, Lowery, Jan T. , Lydum, Laurie, Madlensky, Lisa , Makar, Karen , Maskiell, Judi, McAllister, Pamela K., McGannon, Ellen, McKeown‐Eyssen, Gail, McLaughlin, John, Miller-Pakvasa, Heide, Nguyen, Nathalie , Nigon, Sandy, Parafrey, Patrick, Parry, Susan, Peterson, Susan K. , Phipps, Amanda I. , Redston, Mark , Rogers, Scott O., Schully, Sheri D. , Selander, Teresa, Seminara, Daniella, Shiovitz, Stacey, Siegmund, Kim, Smyrk, Thomas C. , Snazel, Douglas, Stubbs, John, Suthers, Graeme , Thomas, Duncan C. , West, D. P., Woods, Michael O. , Younghusband, Ban, Young, Joanne , Buchanan, Daniel D , Win, Aung K , Jenkins, Mark A , Haile, Robert W , Baron, John A. , Potter, John D. , Hopper, John L. , Casey, Graham , Marchand, Loı̈c Le , Newcomb, Polly A. , Investigators, Colon Cancer Family Registry Cohort, Cheng, Iona C. , Church, James M. , Church, Timothy R. , Clendenning, Mark , Esplen, Mary Jane , Giles, Graham G. , Grady, William M. , Keogh, Louise Anne , Limburg, Paul J. , Macrae, Finlay , Malen, Rachel C. , McLaughlin, John, Möslein, Gabriela , Pollett, Aaron F. , Sandler, Robert David , Southey, Melissa C. , Tucker, Kathy

Mayo Clinic

International Journal of Epidemiology | January 16, 2018 | Volume: 47 | Issue: 2 | Pages: 387-388i

10.1093/ije/dyy006 | PMID 29490034 Get It

Malignancy and Meckel's diverticulum: A systematic literature review and 14‐year experience at a tertiary referral center
Malderen, Kathleen Van , Vijayvargiya, Priya , Camilleri, Michael , van Malderen, Kathleen, Cima, Robert, Larson, David W. , Cima, Robert R.

Mayo Clinic

United European Gastroenterology Journal | January 16, 2018 | Volume: 6 | Issue: 5 | Pages: 739-747

10.1177/2050640617752771 | PMID 30083336 Get It

Background Meckel's diverticulum is present in about 2% of the population. The literature reports 3.2% incidence of tumors within Meckel's diverticulum; the tumors are predominantly benign. Objective and methods The purpose of this study was to evaluate malignant tumors in Meckel's diverticulum through systematic review of the literature and review of electronic medical records including pathology reports over 14 years at the Mayo Clinic, Rochester, USA. Results A literature review over the last 10 years identified 37 citations with 402 patients (median age: 58 years; 68.9% males). The predominant malignancy reported was neuroendocrine tumor 84.6%, followed by gastrointestinal stromal tumor 8.2%, and adenocarcinoma 6%. At the time of diagnosis, 29.5% of patients had metastases. In the Mayo Clinic electronic medical records review, there were 19 patients (5.1% of them surgically removed Meckel's diverticulum) who had a malignancy associated with Meckel's diverticulum: 63.2% neuroendocrine tumor, 10.5% gastrointestinal stromal tumor, 5.3% adenocarcinoma, 5.3% pancreatic epithelial neoplasia, and 15.8% metastases from secondary location. Median size of the malignancy was 7 mm, and 17/19 malignancies were coincidental findings. Most neuroendocrine tumors infiltrated the submucosa, while gastrointestinal stromal tumor and adenocarcinoma invaded the serosa. At the time of diagnosis, 33.3% of patients had metastases. Conclusion About 5% of Meckel's diverticulums resected were associated with malignant tumors, most commonly neuroendocrine tumor, and a significant portion of Meckel's diverticulum malignancy was metastatic at the time of discovery.
Lack of Association between Skewing of X-Chromosome Inactivation in Blood Cells and Colorectal Cancer
Knudsen, Gun Peggy , Riegert‐Johnson, Douglas L. , Meling, GI, Boardman, L.A., Ørstavik, Karen Helene, Boardman, L.A.

Mayo Clinic

The International Journal of Biological Markers | January 16, 2018 | Volume: 23 | Issue: 2 | Pages: 127-128

10.1177/172460080802300211 | PMID 18629787 Get It

Effects of senescence and angiotensin II on expression and processing of amyloid precursor protein in human cerebral microvascular endothelial cells
Sun, Ruohan , He, Tongrong , Pan, Yujun , Katušić, Zvonimir S.

Mayo Clinic

Aging | January 16, 2018 | Volume: 10 | Issue: 1 | Pages: 100-114

10.18632/aging.101362 | PMID 29348391 Get It

Are Clinical Certainty Ratings Helpful in the Diagnosis of Parkinson's Disease?
Gupta, Harsh , Mehta, Shyamal H. , Hentz, Joseph G. , Shill, Holly A. , Driver‐Dunckley, Erika, Belden, Christine M. , Beach, Thomas G. , Sue, Lucia I., Davis, Kathryn, Gupta, Harsh V, Driver-Dunckley, Erika, Adler, C H , Zhang, Nan , Driver‐Dunckley, Erika , Sabbagh, Marwan Noel , Dugger, Brittany N. , Serrano, Geidy E. , Adler, Charles H.

Mayo Clinic

Movement Disorders Clinical Practice | January 15, 2018 | Volume: 5 | Issue: 2 | Pages: 165-170

10.1002/mdc3.12589 | PMID 30363433 Get It

AbstractBackgroundClinical diagnostic criteria for PD rely on rest tremor, bradykinesia, and rigidity. These features are non‐specific and neuropathological confirmation remains the gold standard for diagnosis. This study presents data on clinical certainty ratings in autopsy‐proven PD.MethodsSubjects were assessed annually by a movement disorders specialist and assigned to a clinical certainty group for PD based on multiple clinical features before autopsy. The three groups considered for analysis are as follows: Group I 0–49% certainty, Group II 50‐89% certainty, and Group III 90–100% certainty. All subjects were autopsied and had a standardized neuropathological assessment.Results275 subjects were assigned a PD certainty at their last visit before death. Group I had 80 subjects, Group II 56 subjects, and Group III 139 subjects. The clinical features recorded in Group I, II, and III, were as follows: rest tremor, bradykinesia, rigidity, postural instability, asymmetric onset, persistent asymmetry, current response to dopaminergic treatment, motor fluctuations, and dyskinesia. Rigidity, postural instability, asymmetric onset, current response to dopaminergic treatment, motor fluctuation, and dyskinesia were more likely to be present in the group which was rated with higher certainty. The final diagnosis of PD was confirmed by neuropathological assessment in 85% of the patients in Group III as compared to 30% in Group II and 5% in Group I.ConclusionsHigh certainty (90–100%) had strong positive predictive value (85%) for autopsy‐proven PD as compared to either lower certainty groups (0–49% and 50–89%) which had lower predictive value (5% and 30% respectively).
Review: Newer second-line drugs for diabetes are not more cost-effective than sulfonylureas
Genere, Natalia , Montori, Víctor M.

Mayo Clinic

Annals of Internal Medicine | January 15, 2018 | Volume: 168 | Issue: 2 | Pages: JC8

10.7326/acpjc-2018-168-2-008 | PMID 29335720 Get It

Elevated sympathetic vasomotor outflow in response to increased inspiratory muscle activity during exercise is less in young women compared with men
Katayama, Keisho , Smith, Joshua R. , Goto, Kanako, Shimizu, Kaori, Koike, Teruhiko , Iwase, Satoshi, Koike, Teruhiko , Smith, Joshua R , Saito, Mitsuru , Ishida, Kōji , Harms, Craig A.

Mayo Clinic

Experimental Physiology | January 15, 2018 | Volume: 103 | Issue: 4 | Pages: 570-580

10.1113/ep086817 | PMID 29334157 Get It

New Findings What is the central question of this study? Premenopausal women have an attenuated inspiratory muscle metaboreflex‐induced increase in arterial blood pressure compared with men. It is unclear whether sympathetic vasomotor outflow during dynamic exercise with increased inspiratory muscle activation is less in young women than in men. What is the main finding and its importance? The magnitude of increased sympathetic vasomotor outflow during leg cycling with inspiratory resistance was smaller in women than in men. Less sympathetic vasomotor outflow with inspiratory muscle metaboreflex activation could be one of the mechanisms for the attenuated inspiratory muscle‐induced metaboreflex during exercise in young women. AbstractWe compared changes in muscle sympathetic nerve activity (MSNA) and cardiovascular variables during leg cycle exercise with increased inspiratory muscle resistance in men and women. We hypothesized that sympathetic vasomotor outflow during exercise with increased inspiratory resistance would be attenuated in young women compared with age‐matched men. Eight women and seven men completed the study. The subjects performed two 10 min exercise bouts at 40% peak oxygen uptake using a cycle ergometer in a semirecumbent position [spontaneous breathing for 5 min and voluntary hyperventilation with or without inspiratory resistive breathing for 5 min (breathing frequency 50 breaths min−1 with a 50% duty cycle; inspiratory resistance 30% of maximal inspiratory pressure)]. Mean arterial blood pressure (MAP) was acquired using finger photoplethysmography. The MSNA was recorded via microneurography of the right median nerve at the cubital fossa. During leg cycle exercise with inspiratory resistive breathing, MSNA burst frequency was increased, accompanied by an increase in MAP in both men and women. Women, compared with men, had less of an increase in MAP (women +22.8 ± 12.3 mmHg versus men +32.2 ± 5.4 mmHg; P < 0.05) and MSNA burst frequency (women +9.6 ± 2.9 bursts min−1 versus men +14.6 ± 6.4 bursts min−1; P < 0.05). These results suggest that the attenuated inspiratory muscle‐induced metaboreflex during exercise in young women is attributable, in part, to a lesser sympathetic vasomotor outflow compared with men.
The changing relationship between bronchopulmonary dysplasia and cognition in very preterm infants
Colaizy, Tarah T. , Patel, Neel M., Klein, Jonathan M. , Brumbaugh, Jane E.

Mayo Clinic

Acta Paediatrica | January 15, 2018 | Volume: 107 | Issue: 8 | Pages: 1339-1344

10.1111/apa.14219 | PMID 29333635 Get It

AbstractAimTo characterise the relationship between bronchopulmonary dysplasia (BPD) severity and cognition in the post‐surfactant era.MethodsThis was a single‐centre retrospective analysis of a cohort of infants born 2009–2012. Inclusion criteria were as follows: admission within 48 hours of birth, gestational age 22‐0/7–31‐6/7 weeks, birthweight 400–1500 g and Bayley Scales of Infant and Toddler Development‐III testing at 18–26 months corrected age. Infants (n = 151) were classified by BPD severity with the NIH Workshop definition. Generalised linear modelling and multivariate logistic regression were performed.ResultsBayley cognitive score was not associated with BPD severity in univariate (p = 0.053) or multivariate (p = 0.503) analysis. About 27% of infants with no/mild BPD, 33% of infants with moderate BPD and 40% of infants with severe BPD had a cognitive score <85. There was no difference in the odds of cognitive score <85 based on BPD severity in univariate (p = 0.485) or multivariate analysis (p = 0.225). All infants with cognitive score <70 had severe BPD, although the association between cognitive score <70 and BPD severity was not significant.ConclusionWe found no independent effect of BPD severity level on cognition. The likelihood of a cognitive score <85 was not associated with BPD severity.
Multi-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer
Xi, Mian , Yang, Yadi, Zhang, Li , Merrell, Kenneth W. , Hallemeier, Christopher L. , Haddock, Michael G. , Hofstetter, Wayne L. , Ho, Linus, Liu, Mengzhong , Shen, Robert K, Yang, Hong Qiong , Hallemeier, Christopher Leigh , Shen, Robert K. , Maru, Dipen Maheshbhai , Wu, Carol C. , Lin, Steven H.

Mayo Clinic

Annals of Surgery | January 15, 2018 | Volume: 269 | Issue: 4 | Pages: 663-670

10.1097/sla.0000000000002670 | PMID 29334555 Get It

Objective: To determine the impact of histology on pathologic response, survival outcomes, and recurrence patterns in patients with esophageal cancer (EC) who received neoadjuvant chemoradiotherapy (CRT). Summary of Background Data: There is a paucity of data regarding comparative outcomes after neoadjuvant CRT between esophageal squamous cell carcinoma (SCC) and adenocarcinoma. Methods: Between 2002 and 2015, 895 EC patients who underwent neoadjuvant CRT followed by esophagectomy at 3 academic institutions were retrospectively reviewed, including 207 patients with SCC (23.1%) and 688 patients with adenocarcinoma (76.9%). Pathologic response, survival, recurrence pattern, and potential prognostic factors were compared. Results: Pathologic complete response (pCR) rate was significantly higher for SCC compared with adenocarcinoma (44.9% vs 25.9%, P < 0.001). After a median follow-up of 52.9 months, 71 patients (34.3%) with SCC versus 297 patients (43.2%) with adenocarcinoma had recurrent disease (P = 0.023). For patients who achieved a pCR, no significant differences were found in recurrence pattern, sites, or survival end-points between the 2 histology groups. For non-pCR patients, the SCC group demonstrated significantly higher regional and supraclavicular recurrence rates but a lower hematogenous metastasis rate than adenocarcinoma patients, whereas the adenocarcinoma patients had a more favorable locoregional failure-free survival (P = 0.005) and worse distant metastasis-free survival (P = 0.024). No differences were found in overall survival (P = 0.772) or recurrence-free survival (P = 0.696) between groups. Conclusions: SCC was associated with a significantly higher pCR rate than adenocarcinoma. Recurrence pattern and survival outcomes were significantly different between the 2 histology subtypes in non-pCR patients.
Associations between type I interferon and antiphospholipid antibody status differ between ancestral backgrounds
Iwamoto, Taro , Dorschner, Jessica M., Jolly, Meenakshi , Huang, Xiangyang, Niewold, Timothy B. , Dorschner, Jessica

Mayo Clinic

Lupus Science & Medicine | January 13, 2018 | Volume: 5 | Issue: 1 | Pages: e000246

10.1136/lupus-2017-000246 | PMID 29387437 Get It

Objective The type I interferon pathway is activated in many patients with systemic lupus erythematosus (SLE), and anti-double-stranded DNA (dsDNA) and anti-RNA binding protein autoantibodies are correlated with high interferon-α (IFNα) activity. We studied whether antiphospholipid (APL) antibodies, which should not stimulate Toll-like receptors, are also associated with high levels of IFNα activity. Methods Serum IFNα activity was measured in patients with SLE using the WISH cell bioassay. IgG APL, anti-RBP and anti-dsDNA antibodies were measured in the clinical laboratory, and standard clinical cut-offs were used to define the positive results. Results High IFNα activity was associated with anti-RBP and anti-dsDNA antibodies in all three ancestral backgrounds. Strikingly, African-American subjects with a positive APL antibody test had higher IFNα activity than those without IgG APL antibodies. This was not shared with other ancestral backgrounds. This finding was independent of other autoantibody profiles, and clinical features did not differ between IgG APL antibody positive versus negative African-American patients. Conclusion The difference in association between IFNα activity and IgG APL status between ancestral backgrounds supports differences in molecular pathogenesis. This may suggest B cell hyperactivity in the setting of type I IFN in African-Americans and could suggest ways to individualise therapy.